Comparison of Virologic, Immunologic, and Clinical Response to Five Different Initial Protease Inhibitor‐Containing and Nevirapine‐Containing Regimens

Keywords

Saquinavir, Nelfinavir, Ritonavir, Medicine, Regimen

References

No references recorded for this paper.

Cited by

• The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databases.Sri Suryanti — 2006
• Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinicJ. L. Gregg — 2010
• Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?The Antiretroviral Therapy Cohort Collaboration (ART-CC) — 2008
• Characterization of treatment failure in HIV positive patients in the Colombian Caribbean regionJuan M. de la Hoz, Laura Bolaño, Oriana Cárdenas — 2014
• Persistent low‐level viraemia and virological failure in HIV‐1‐infected patients treated with highly active antiretroviral therapySomnuek Sungkanuparph, RK Groger, Edgar T. Overton — 2006
• Cohort studies: to what extent can they inform treatment guidelines?Caroline Sabin — 2010
• Hepatotoxicity Associated with Long-versus Short-Course HIV-Prophylactic Nevirapine UseJune M. McKoy, Charles L. Bennett, Marc H. Scheetz — 2009
• Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor‐naive HIV‐infected patients: the Swiss HIV Cohort StudyHC Bucher, M. Bichsel, Patrick Taffé — 2002
• Initiating Highly Active Antiretroviral Therapy with Newer Protease Inhibitors Is Associated with Better Survival Compared to First-Generation Protease Inhibitors or NevirapineHeidi M. Crane, Stephen E. Van Rompaey, Mari M. Kitahata — 2007
• Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studiesEvan Wood, Robert S. Hogg, Katherine Heath — 2003
• Predictors of Antiretroviral Treatment Failure in an Urban HIV ClinicGregory K. Robbins, Brock Daniels, Hui Zheng — 2007
• The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infectionMarina B. Klein, Patrick Willemot, Tanya Murphy — 2004
• Serious Adverse Cutaneous and Hepatic Toxicities Associated With Nevirapine Use by Non–HIV-Infected IndividualsShilpa M. Patel, Stuart Johnson, Steven M. Belknap — 2004
• Diarrhées et infection à VIHP. Dellamonica — 2003
• HIV Dynamics and Integrase InhibitorsJohn M. Murray — 2009
• Comparison of single and boosted protease inhibitor versus nonnucleoside reverse transcriptase inhibitor-containing cART regimens in antiretroviral-naïve patients starting cART after January 1, 2000.A. Mocroft, A. Horban, N. Clumeck — 2006
• Treatment Outcome and Cost-Effectiveness of Different Highly Active Antiretroviral Therapy Regimens in the Uk (1996–2002)E. J. Beck, Sundhiya Mandalia, M Youle — 2008
• A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads.Alessandro Cozzi‐Lepri, Andrea De Luca, Andrew Phillips — 2006
• Análise e Caracterização Molecular, Estrutural e Populacional de Proteases de HIV-1 do Estado de São PauloGraduação em Microbiologia — 2012
• Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppressionAndrew Phillips, Bruno Ledergerber, Andrzej Horban — 2004

Related papers

• Pharmacokinetic Interactions between HIV‐1 Protease Inhibitors in Rats: Study on Combinations of Two Kinds of HIV‐1 Protease InhibitorsNobuhito Shibata, Yasuhiro Matsumura, Hiroyuki Okamoto — 2000
• Simultaneous HPLC assay for quantification of indinavir, nelfinavir, ritonavir, and saquinavir in human plasma.Rory P. Remmel, Sagar P. Kawle, Dennis R. Weller — 2000
• Simultaious determination of the HIV protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.Patricia W. H. Hugen, C.P.W.G.M. Verwey-van Wissen, David M. Burger — 1999
• Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.Rolf P. G. van Heeswijk, Rmw Hoetelmans, Remko Harms — 1998
• Effect of protease inhibitors on the sense of taste.Susan S. Schiffman, Jennifer Zervakis, Sean Heffron — 1999
• The Safety and Antiviral Effect of Protease Inhibitors in ChildrenMary E Temple, Katalin Korányi, Milap C. Nahata — 2001
• Therapeutic Drug Monitoring of HIV Protease Inhibitors Using High-Performance Liquid Chromatography With Ultraviolet or Photodiode Array DetectionP. Leibenguth, Chantal Le Guellec, Jean‐Marc Besnier — 2001
• Sensitive and Rapid Method for the Simultaneous Quantification of the HIV-Protease Inhibitors Indinavir, Nelfinavir, Ritonavir, and Saquinavir in Human Plasma by Reversed-Phase Liquid ChromatographyM. Bouley, Corinne Briere, Christophe Padoin — 2001